Gemcitabine with or without docetaxel and resection for recurrent osteosarcoma: The experience at children's memorial hospital

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 2, 2012, Pages

  Gosiengfiao, Yasmin ^a,b   Reichek, Jennifer ^a,b   Woodman, Jill ^a   Ben Ami, Tamar ^a,b   Walterhouse, David ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

gemcitabine; osteosarcoma; pediatric; recurrent; refractory

Indexed keywords

DEXAMETHASONE; DOCETAXEL; GEMCITABINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CHILD; CHONDROSARCOMA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MALE; METASTASIS RESECTION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OSTEOSARCOMA; OUTCOME ASSESSMENT; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; OSTEOSARCOMA; RETROSPECTIVE STUDIES; TAXOIDS; TREATMENT OUTCOME;

EID: 84857914348     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182331ee8     Document Type: Article

References (6)

1. Merimsky O, Meller I, Flusser G, et al. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: A phase II study. Cancer Chemother Pharmacol. 2000;45:177-181.
2. Merimsky O, Meller I, Kollender Y, et al. Gemcitabine in bone sarcoma resistant to doxorubicin-based chemotherapy. Sarcoma. 2000;4:7-10.
3. Navid F, Willert JR, McCarville MB, et al. Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma. Cancer. 2008; 113:419-425.
4. Leu KM, Ostruszka LJ, Shewach D, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. J Clin Oncol. 2004;22:1706-1712.
5. Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: Results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007;25:2755-2763.
6. Mora J, Cruz CO, Parareda A, et al. Treatment of relapsed/ refractory pediatric sarcomas with gemcitabine and docetaxel. J Pediatr Hematol Oncol. 2009;31:723-729.